We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

NOG:NYSENorthern Oil and Gas, Inc. Analysis

Data as of 2026-06-22 - not real-time

$19.44

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Technical outlook: NOG is trading at $19.44, well below its 20‑day ($21.36), 50‑day ($23.89) and 200‑day ($24.33) simple moving averages, signaling a sustained bearish price trend. The 14‑day RSI sits at 31, indicating oversold conditions, while the MACD remains in a bearish configuration (line below signal, negative histogram). Volume is increasing, but the 30‑day volatility of 42% underscores a highly erratic price environment.
Fundamental backdrop: The company reports a forward P/E of 4.66 versus an industry average of 20, and a DCF‑derived fair value of $97.26, suggesting substantial upside potential (over 70% upside). However, the balance sheet is strained with a debt‑to‑equity ratio of 143 and a payout ratio exceeding 460%, casting doubt on the sustainability of its 9.26% dividend. Recent news of raised 2026 production guidance and new acquisitions provides a positive catalyst, but the high leverage and negative earnings margins remain key concerns.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • Price below all major SMAs indicating continued downtrend
  • RSI oversold but MACD bearish
  • Elevated volatility and high debt limit upside potential

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Raised production guidance and recent acquisitions supporting revenue growth
  • Forward P/E of 4.66 and DCF fair value far above current price
  • Increasing volume suggests growing investor interest despite leverage

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Potential for debt reduction through strong operating cash flow
  • Significant upside to DCF fair value if earnings normalize
  • Blend of value (high dividend yield) and growth (production expansion) attributes

Key Metrics & Analysis

Financial Health

Revenue Growth-7.10%
Profit Margin-32.36%
P/E Ratio4.7
ROE-29.77%
ROA4.31%
Debt/Equity142.99
P/B Ratio1.1
Op. Cash Flow$1.4B
Free Cash Flow$-13380500
Industry P/E20.1

Technical Analysis

TrendBearish
RSI31.2
Support$18.75
Resistance$24.62
MA 20$21.36
MA 50$23.89
MA 200$24.33
MACDBearish
VolumeIncreasing
Fear & Greed Index91.46

Valuation

Fair Value$97.26
Target Price$33.67
Upside/Downside73.18%
GradeUndervalued
TypeBlend
Dividend Yield9.26%

Risk Assessment

Beta0.13
Volatility42.08%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.